Concordance between different trophectoderm biopsy sites and the inner cell mass of chromosomal composition measured with a next-generation sequencing platform

被引:52
|
作者
Chuang, Tzu-Hsuan [1 ]
Hsieh, Jhih-Yuan [1 ]
Lee, Meng-Ju [1 ]
Lai, Hsing-Hua [1 ]
Hsieh, Chia-Lin [1 ]
Wang, Huai-Lin [1 ]
Chang, Yu-Jen [2 ]
Chen, Shee-Uan [3 ]
机构
[1] Stork Ladies Clin, Stork Fertil Ctr, 80 Zhongxiao Rd, Hsinchu 30069, Taiwan
[2] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, 331 Shipin Rd, Hsinchu 30062, Taiwan
[3] Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, 8 Chung Shan South Rd, Taipei, Taiwan
关键词
preimplantation genetic screening; confined mosaicism; next-generation sequencing; chromosome concordance; aneuploid percentage; PREIMPLANTATION EMBRYOS; SEGMENTAL ANEUPLOIDIES; CYTOGENETIC ANALYSIS; BLASTOCYST BIOPSY; AMNIOTIC-FLUID; FOLLOW-UP; MOSAICISM; DIAGNOSIS; INSIGHTS; ORIGIN;
D O I
10.1093/molehr/gay043
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
STUDY QUESTION: In PGS, does chromosomal constitution differ among trophectoderm (TE) biopsy sites and between them and the inner cell mass (ICM)? SUMMARY ANSWER: The ploidy concordance between ICM and TE was independent of whether the biopsy site in the TE was near to or far from the ICM. WHAT IS KNOWN ALREADY: TE biopsies are considered less harmful to developing embryos than blastomere biopsies. Removal of multi-cellular samples permits high-resolution next-generation sequencing (Veriseq NGS) to detect aneuploidy present in a minority of cells (mosaicism of diploid and aneuploid cells). However, the prevalence of ploidy discrepancies between different TE biopsy sites and the ICM, as well as confined mosaicism (aneuploidy only in a particular area), has not been established. STUDY DESIGN, SIZE, DURATION: Biopsies were taken from a site opposite to the ICM (TE1), near the ICM (TE2) and within the ICM of the same embryo in 33 donated blastocysts obtained from 12 volunteer patients. The samples were analyzed by the Veriseq NGS to assess ploidy concordance. PARTICIPANTS/MATERIALS, SETTING, METHODS: The mean age of the patients was 34.4 years, and samples from all three biopsy sites were achieved in 29 frozen thawed blastocysts. The aneuploid percentage in each sample was interpreted by Veriseq NGS at the finest resolution involving the number of reads after filtering, sample overall noise score, and average quality/alignment scores according to the Veriseq quality control assessment. Ploidy concordance was then assessed between different TE fractions, and between the TE and ICM. MAIN RESULTS AND THE ROLE OF CHANCE: The euploid rates were similar in the TEs and ICM, and no preferential allocation of euploid lineage within a blastocyst was demonstrated. Whether the biopsy site in the TE was near to or far from the ICM, the chromosomal consistency rate was similar [TE1-to-ICM, 86.2% (25/29) versus TE2-to-ICM, 89.7% (26/29); P = 1.0], suggesting that the cells with different chromosomal components may spread randomly throughout the TE. The following two types of inconsistent PGS conclusions between TE and ICM due to confined mosaicism were observed: (i) euploid TE with mosaic ICM (3%) (1/29); and (ii) mosaic TE with euploid ICM (3%) (1/29) or with aneuploid ICM (7%) (2/29). Thus, the overall rate of confined mosaicism was 14% (4/29). LARGE SCALE DATA: N/A. LIMITATION, REASONS FOR CAUTION: The approach used in the present study was affected by biopsy manipulation limitations involving possible cell contamination and the technical challenge of comprehensive chromosomal screening (CCS) procedures. WIDER IMPLICATIONS OF THE FINDINGS: The rate of confined mosaicism in the blastocysts was estimated in this preliminary study, thus, specifying the incidence of biological sampling biases. The results also verified the random distribution of different cell lineages, and the representative value of a single biopsied sample from the TE.
引用
收藏
页码:593 / 601
页数:9
相关论文
共 50 条
  • [31] Concordance in Oncogenic Alterations between Primary and Recurrent/Metastatic Cholangiocarcinoma Pairs Using Targeted Next-Generation Sequencing
    McIntyre, Sarah M.
    Preston, William
    Walch, Henry
    Sigel, Carlie
    Sharib, Jeremy
    Chen, Wei
    Lidsky, Michael E.
    Kundra, Ritika
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Balachandran, Vinod P.
    Drebin, Jeffrey A.
    Soares, Kevin C.
    Wei, Alice C.
    Kingham, Peter
    D'Angelica, Michael I.
    Iacobuzio-Donahue, Christine
    Schultz, Nikolaus
    Jarnagin, William R.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S174 - S174
  • [32] Concordance of Tissue and Cell-Free DNA-Based Next-Generation Sequencing in Patients With Lung Adenocarcinoma
    Tran, M.
    Strohbehn, G.
    Rouhani, S.
    Shergill, A.
    Hoffman, P.
    Patel, J.
    Segal, J.
    Vokes, E.
    Bestvina, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1032 - S1032
  • [33] Optimizing Diagnostic Algorithms for Pediatric Leukemia: Synergy Between Next-generation Sequencing, Chromosomal Microarray, and Conventional Cytogenetics
    Hiemenz, M. C.
    Ji, J.
    Schmidt, R. J.
    Oberley, M. J.
    Bhojwani, D.
    Biegel, J. A.
    Raca, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 933 - 933
  • [34] Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing.
    McIntyre, Sarah Margaret Helena
    Preston, William
    Walch, Henry S.
    Sigel, Carlie S.
    Sharib, Jeremy
    Chen, Wei
    Lidsky, Michael
    Kundra, Ritika
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Balachandran, Vinod P.
    Drebin, Jeffrey A.
    Soares, Kevin
    Wei, Alice Chia-chi
    Kingham, T. Peter
    D'Angelica, Michael Ian
    Iacobuzio-Donahue, Christine A.
    Schultz, Nikolaus
    Jarnagin, William R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 604 - 604
  • [35] Chromosomal scan of single sperm cells by combining fluorescence-activated cell sorting and next-generation sequencing
    Quoc Ty Tran
    Jatsenko, Tatjana
    Poolamets, Olev
    Tsuiko, Olga
    Lubenets, Dmitri
    Reimand, Tiia
    Punab, Margus
    Peters, Maire
    Salumets, Andres
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2019, 36 (01) : 91 - 97
  • [36] Chromosomal scan of single sperm cells by combining fluorescence-activated cell sorting and next-generation sequencing
    Quoc Ty Tran
    Tatjana Jatsenko
    Olev Poolamets
    Olga Tšuiko
    Dmitri Lubenets
    Tiia Reimand
    Margus Punab
    Maire Peters
    Andres Salumets
    Journal of Assisted Reproduction and Genetics, 2019, 36 : 91 - 97
  • [37] High concordance between next-generation sequencing and single-nucleotide polymorphism array in preimplantation genetic testing for aneuploidy
    Ou, Zhanhui
    Chen, Zhiheng
    Deng, Yu
    Sun, Ling
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (01):
  • [38] Concordance of MET Amplification between Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS) in Non-Small Cell Lung Carcinoma (NSCLC)
    Ren, Rongqin
    Shiller, Michelle
    Chandra, Pranil
    Crawford, Eric
    Coldren, Christopher
    Yin, Lihui
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1654 - S1654
  • [39] Evaluation of chromosomal abnormalities from preimplantation genetic testing to the reproductive outcomes: a comparison between three different structural rearrangements based on next-generation sequencing
    Ping Yuan
    Lingyan Zheng
    Songbang Ou
    Haijing Zhao
    Ruiqi Li
    HongJiao Luo
    Xin Tan
    Qingxue Zhang
    Wenjun Wang
    Journal of Assisted Reproduction and Genetics, 2021, 38 : 709 - 718
  • [40] Evaluation of chromosomal abnormalities from preimplantation genetic testing to the reproductive outcomes: a comparison between three different structural rearrangements based on next-generation sequencing
    Yuan, Ping
    Zheng, Lingyan
    Ou, Songbang
    Zhao, Haijing
    Li, Ruiqi
    Luo, HongJiao
    Tan, Xin
    Zhang, Qingxue
    Wang, Wenjun
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (03) : 709 - 718